Choose a Region Customer Portals Contact Us
Americas
Argentina Brazil Canada Colombia México United States
Europe
Adriatic Netherlands Belgium Nordics Bulgaria Poland Czech Republic Portugal Germany Romania España Russia France Slovakia Greece Switzerland Hungary Turkey Ireland Ukraine Israel United Kingdom Italy
Asia & Oceania
Asia Pacific Australia & NZ China India Japan Korea Southeast Asia Sri Lanka
Middle East & Africa
Middle East and Africa
EMEA Thought Leadership
Americas
Europe, Middle East & Africa
Asia Pacific
Choose a Region Customer Portals Contact Us
Americas
Argentina Brazil Canada Colombia México United States
Europe
Adriatic Netherlands Belgium Nordics Bulgaria Poland Czech Republic Portugal Germany Romania España Russia France Slovakia Greece Switzerland Hungary Turkey Ireland Ukraine Israel United Kingdom Italy
Asia & Oceania
Asia Pacific Australia & NZ China India Japan Korea Southeast Asia Sri Lanka
Middle East & Africa
Middle East and Africa
EMEA Thought Leadership
Americas
Europe, Middle East & Africa
Asia Pacific
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences Solutions
  • Healthcare Solutions
  • Medical Device and Diagnostic
  • U.S. Government
Life Sciences Solutions

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences Solutions
Healthcare Solutions

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare Solutions
Medical Device and Diagnostic Solutions

Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.

Learn More
Medical Device and Diagnostic Solutions
U.S. Government Solutions

For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.

Learn More
U.S. Government Solutions
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

FEATURED WEBINAR

"Top Issues for Pharma to Watch in 2022 and 2023

WATCH NOW
MAIN/Contact Us
Contact Us/
White Paper
Can 340B Modifiers Avoid Duplicate Discounts in the IRA?
Feb 21, 2023
To download files you must give consent to process your personal data by clicking the "Accept" button below.

This study explores the impact of The Inflation Reduction Act (IRA) of 2022 on 340B Modifiers. In August 2022, the IRA introduced provisions requiring the identification of 340B transactions. 340B modifiers — a system of codes used on some pharmacy and medical claims to identify 340B drugs — have been required by the Centers for Medicare & Medicaid Services (CMS) for Medicare Part B reimbursement, and more recently, to identify 340B drugs. Download this white paper for a deeper look into 340B Modifiers data and the impact it will have on the industry.

For a summary of this study and paper please see our fact sheet here

Related solutions

Market Access

Gain high value access and increase the profitability of your brands

Contact Us